Filed under
Regulation & Industry
FDA actions, legal status, and industry developments.
-
FDA Peptide Vote 2026: What the Committee Decided
FDA’s Pharmacy Compounding Advisory Committee recommended BPC-157, KPV, TB-500, MOTS-c, Semax and Epitalon for the 503A bulks list on July…
-
FDA Rules on Research Chemicals: 2026 Changes
What if the long-standing reliance on animal-based toxicology is no longer the definitive benchmark for regulatory validation? For years, the…